Main Conference

APPLY TO SPEAK

BOOK YOUR TICKET

The World Drug Safety Congress Americas is the largest, most established meeting dedicated to drug safety in the Americas – providing the most up to date, keynote-driven content surrounding the pharmacovigilance space.

From real world evidence & data analytics to safety in advanced therapies, this one meeting covers the whole drug safety value chain where industry leaders, government and developers all come together to create groundbreaking progress.

Our world class conference features the following themes

AI & Automation

AI & Automation
Discover how artificial intelligence and automation are transforming pharmacovigilance processes, enhancing efficiency, accuracy, and drug safety monitoring.

Global PV

Global PV
Explore global trends in pharmacovigilance and how international regulatory requirements shape drug safety practices.

Regulatory

Regulatory
Stay updated on the latest regulatory developments in drug safety internationally and how to ensure compliance with evolving guidelines

Safety Risk Management

Safety Risk Management
Learn advanced strategies for identifying, assessing, and mitigating risks throughout the drug development lifecycle

Next Gen Tech & Data

Next Gen Tech & Data
Learn first-hand how next-generation technologies and data analytics are revolutionizing pharmacovigilance and enhancing drug safety monitoring.

Real-World Evidence & Data Analytics

Real-World Evidence & Data Analytics
Understand the role of real-world data in generating insights that improve drug safety and patient outcomes.

Patient Centricity

Patient Centricity
Dive into how placing patients at the center of drug safety efforts improves care, reporting, and risk management

PV Education & Training

PV Education & Training
Gain insights into effective PV training programs that ensure a skilled and knowledgeable workforce in drug safety.

PV Outsourcing

PV Outsourcing
Discuss the benefits and challenges of outsourcing pharmacovigilance operations to external partners.

Innovation & Partnerships

Innovation & Partnerships
Learn how collaborations and partnerships are driving innovation in drug safety and pharmacovigilance.

Compliance

Compliance
Hear best practices on navigating the complexities of ensuring drug safety compliance with stringent local and global regulations.

Quality Assurance

Quality Assurance
Explore the importance of maintaining high-quality standards in pharmacovigilance to protect patient safety.

Safety in Advanced Therapies

Safety in Advanced Therapies
Address the unique safety challenges posed by advanced therapies such as gene and cell therapies.

Vaccine Safety

Vaccine Safety
Discuss the latest strategies and challenges in monitoring the safety of vaccines in a rapidly evolving landscape.

MedTech

MedTech
Understand the intersection of pharmacovigilance and medical technology, focusing on the safety monitoring of medical devices.

APPLY TO SPEAK

DOWNLOAD PROSPECTUS

Highlighted Speakers

Han Ma
Chief Safety Officer
BeiGene USA, Inc.

Han Ma speaking at World Drug Safety Congress

Serban Ghiorghiu
Chief Safety Officer

AstraZeneca

Serban Ghiorghiu speaking at speaking at World Drug Safety Congress

Rania Mouchantaf, PhD
Executive Director
Health Canada

Rania Mouchantaf, PhD speaking at World Drug Safety Congress

Peter Hjelmstrom
Director and CEO
Uppsala Monitoring Centre

Peter Hjelmstrom speaking at World Drug Safety Congress

Jose Vega
Chief Safety Officer
Moderna Therapeutics

Jose Vega speaking at World Drug Safety Congress

Yvonne Nanciu
Country Head, PV, Deputy EU QPPV
Bayer

Yvonne Nanciu speaking at World Drug Safety Congress

Badrish Patel
VP, Global Drug Safety & PV
Jazz Pharmaceuticals

Badrish Patel speaking at World Drug Safety Congress

Claudia Manzo
Head of the Office of Risk Management PV & Patient Safety
AbbVie

Claudia Manzo speaking at World Drug Safety Congress

Mamiko Kasho
Executive Director, Head of Pharmacovigilance Operations
Eisai

Mamiko Kasho speaking at World Drug Safety Congress

Felix Arellano
Global Head of PV & Drug Safety
Roche

Felix Arellano speaking at speaking at World Drug Safety Congress

Reema Mehta
VP, Head of Risk Assessment & Management
Pfizer

Reema Mehta speaking at World Drug Safety Congress

Narayan Nair
Division Director for Division of PV, Center for Biologics Evaluation & Research
FDA

Narayan Nair speaking at World Drug Safety Congress

FREE ACCESS for Pharmaceuticals, Biotech, Hospitals and Academia Groups

Apply for your free pass below to secure your spot

Get Involved At Drug Safety Congress Americas

CONNECT WITH US

For Sponsorship and Exhibition opportunities

Semen Sen
semen.sen@terrapinn.com
t/ + 646-619-1793

To Speak

Kaylee Nguyen
kaylee.nguyen@terrapinn.com

Marketing & Press
Opportunities

Kaylie Brogan
kaylie.brogan@terrapinn.com